Interestingly, the levels of urinary SARS-CoV-2 N and plasma albumin did not correlate directly (Figure 2A), suggesting that combining urinary SARS-CoV-2 N and plasma albumin could further improve risk stratification for AKI in COVID-19. This evidence concerns the gene ALB and acute kidney injury.